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Abstract
Background: Based on growing evidence that some adult multipotent cells necessary for tissue regeneration reside in the
walls of blood vessels and the clinical success of vein wrapping for functional repair of nerve damage, we hypothesized that
the repair of nerves via vein wrapping is mediated by cells migrating from the implanted venous grafts into the nerve
bundle.
Methodology/Principal Findings: To test the hypothesis, severed femoral nerves of rats were grafted with venous grafts
from animals of the opposite sex. Nerve regeneration was impaired when decellularized or irradiated venous grafts were
used in comparison to untreated grafts, supporting the involvement of venous graft-derived cells in peripheral nerve repair.
Donor cells bearing Y chromosomes integrated into the area of the host injured nerve and participated in remyelination and
nerve regeneration. The regenerated nerve exhibited proper axonal myelination, and expressed neuronal and glial cell
markers.
Conclusions/Significance: These novel findings identify the mechanism by which vein wrapping promotes nerve
regeneration.
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Introduction
Wrapping the scarred nerves with autogenous vein grafts has
been used effectively for the treatment of peripheral neuropathy in
both experimental and clinical settings [1–17]. In clinic, results of
these studies have shown improvement of the nerve function and
the symptoms associated with recurrent compressive peripheral
neuropathy [5–10], [12], [13], [17], carpal tunnel syndrome [6],
[14], tarsal tunnel syndrome [8], cubital tunnel syndrome [17],
prevention of scar formation [4], [7], [11], and alleviation of
painful neuroma [15], [16]. The concept that the walls of blood
vessels are a reservoir of ubiquitous multi-lineage cells has largely
emerged by the description of mesoangioblasts and hematopoietic
stem cells [18], [19]. A vascular niche for adult hippocampal
neurogenesis was identified [20] and endothelial cells were
recognized as a critical component for secreting soluble factors
that maintain the self-renewal and multipotency of neural stem
cells [21]. More recently, adipose vasculature has been identified
as a niche where white fat progenitor cells reside [22], and our
publications also describe a perivascular origin for multipotent
myoendothelial cells and pericytes in human skeletal muscle [23],
[24].
Herein, to explore our hypothesis that the healing of peripheral
nerves is mediated by vascular cells from the venous grafts, we
examined the migration of the cells derived from vascular walls in
nerve repair by altering the venous grafts prior to transplantation
using decellularization (complete cell removal) and irradiation
(preventing cell migration and proliferation) methods. Active
participation of the donor vascular cells in the remyelination of the
injured nerve was determined by bridging the peripheral nerve
defects created in female rats using donor male venous grafts.
Results
Irradiation inhibits cell migration and proliferation in
venous grafts
To determine the effectiveness of decellularization or irradiation
on venous grafts before transplantation, parallel experiments were
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performed where pieces (,1–2 mm) from untreated (control),
irradiated, and decellularized (SDS-treated) veins were placed in
fibronectin-coated 24-well plates in endothelial cell growth
medium-2 (EGM2, n= 3). In order to optimize the irradiation
dose used on the excised veins we assessed doses of 1000, 2000,
5000, and 10,000 rad. The dose of 1000-rad was chosen because it
limited cell damage and preserved the integrity of the vein grafts.
This radiation dose has also been shown to prevent human
endothelial cell replication [25]. Upon culturing venous grafts on
fibronectin-coated 24-well plates in EGM2, many cells were seen
to migrate out of the normal untreated vein after 7 days in culture
(Fig. 1A), very few cells migrated out from the irradiated veins
(Fig. 1A), and no cells migrated from the decellularized vein
explants (data not shown) as previously reported by Schaner et al.
[26]. Cells were still visible at the edges of the untreated and
irradiated veins after 14 days of culture (Fig. 1B, arrows), but
continuously outgrew only from the untreated explants (Fig. 1B,
arrowheads) as a mixture of progenitor cells that make up the walls
of blood vessels (Fig. 1C). The viability of clustered cells attached
to the irradiated veins was verified using the MTT [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. Al-
though the cells appeared to be viable (Fig. 1C, purple), the cells
could not migrate out of the vein even after 25 days. In addition, to
evaluate the proliferation of viable cells, an equivalent number of
cells from untreated and irradiated veins were plated to measure
their growth kinetics. Analysis of the cell number over a period of
10 days revealed that the number of cells from the untreated
venous grafts significantly increased (P,0.001) compared to the
cells from irradiated veins (Fig. 2). These data demonstrated that
irradiation diminishes cell migration and proliferation potential.
Cells from venous grafts contribute to nerve
regeneration
The role of venous graft-derived cells in the nerve repair process
was determined by using venous grafts that were either irradiated
or decellularized prior to their implantation. The regeneration
process was then compared among the treated and untreated graft
groups. To investigate whether the nerve regeneration is mediated
by venous graft-derived cells, peripheral nerve lesions were
bridged using venous conduits in a rat sex-mismatch model
(Fig. 3) and fluorescence in situ hybridization (FISH) was used to
detect male donor-derived Y chromosome positive nuclei in the
regenerated female host nerves. Proper nerve regeneration four to
six weeks after implantation was assessed using histochemistry,
immunohistochemistry, and electron microscopy.
At the time of harvest, the vein grafts could be identified by
microscopy in all the groups without any sign of absorption or
degeneration. Minimal scar or adhesions were noticed between the
nerve and the vein graft, although some scarring was evident in
recipients of the irradiated veins. Complete femoral nerve
regeneration was observed in all of the rats that received untreated
control vein grafts, while the recipients of the irradiated and
decellularized veins exhibited only minimal regeneration. Six to
eight weeks after transplantation, Masson’s Trichrome staining of
the nerves implanted with irradiated and decellularized grafts
(Fig. 4A) showed a reduced number of myelinated axons (no
traces of pink stain) and a greater amount of collagen deposition
(intense blue stain), when compared to nerves with untreated
grafts. The regenerated nerve in untreated venous grafts showed a
well-organized architecture of myelinated nerve fibers, including
less fibrotic tissue (collagen, blue) between fascicles (epineurium)
Figure 1. Cell migration is inhibited by irradiation. The normal untreated and irradiated veins were separately cultured on fibronectin-coated
culture plates in EGM2 culture media. (A) Many cells migrated out of the untreated vein after 7 days in culture, while very few cells were detected in
the culture dishes containing the irradiated vein. (B) Cells were still visible at the edges of the untreated and irradiated veins (arrows) after 14 days of
culture, and continuously outgrew from the untreated veins (arrowheads). (C) Untreated venous graft-derived cells showed a diverse morphology;
while clustered cells in the irradiated vein did not migrate out of the vein even after 25 days of culture but remained viable as verified by the MTT
assay (purple). Data represent at least three independent experiments. Scale bars represent 200 mm (A) or 100 mm (B and C).
doi:10.1371/journal.pone.0024801.g001
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and within individual axons (endoneurium) (Fig. 4A). Regener-
ated nerves in untreated grafts exhibited many neurofilament-
positive axons (green) surrounded with myelin sheaths positive for
FluoroMyelin (red), as compared to other experimental groups
(Fig. 4B), suggesting proper formation of mature myelinated
axons at the site of nerve regeneration. This pattern of maturation
was not apparent in recipients of irradiated or decellularized veins
(Fig. 4B). Toluidine blue staining (Fig. 4C), and TEM images of
the same sections (Fig. 4D) revealed that the decellularized and
irradiated veins induced only scattered regeneration in the form of
small axons with thin myelin sheets and more prominent
thickening of the extracellular matrix compared to recipients of
untreated venous grafts (Fig. 4C–D).
Morphometric parameters such as the number of myelinated
axons, myelin thickness, myelinated fiber area, axonal area, and g-
ratio were quantitatively measured in the mid-section of the
regenerated nerves using toluidine blue and TEM images
(Table 1). Eight to ten weeks after transplantation, the number
of the regenerated myelinated axons was not significantly different
between the treatment groups (P=0.760) when compared to
untreated femoral nerves; however, there were more myelinated
axons with significantly greater diameters in uninjured control
nerves and nerves grafted with untreated vein grafts, compared to
nerves associated with irradiated and decellularized vein grafts.
Median values for myelinated fiber area and myelin thickness in
irradiated and decellularized graft groups were significantly
smaller than in the untreated graft group (P,0.05). The median
axonal area and the g-ratio, which describes the relationship
between axon caliber and myelinated fiber caliber, were
significantly smaller in the irradiated and decellularized vein graft
groups when compared to the untreated grafts and uninjured
control groups (P,0.05). There was no significant difference seen
in the median axonal area and g-ratio between the untreated graft
and uninjured control nerve groups, suggesting that untreated
venous grafts contributed considerably to nerve regeneration. This
is in stark contrast to the irradiated and decellularized vein graft
groups which failed to regain their normal axon diameter and
presented with numerous regenerating fibers that were surrounded
Figure 3. Surgical procedures for isolation and implantation of venous graft. A five to six mm segment of pure femoral vein from a male
Fisher rat was isolated, pulled over a 0.2 mm forceps (vessel dilator, A) and placed in sterile PBS for later use. The right femoral nerve from a female
rat was exposed, and a 5 mm segment of peripheral nerve was carefully separated so as not to disturb the attached artery and vein compartment.
Using surgical scissors, neurotomy was performed in the middle of the femoral nerve of a female Fisher rat (B). The distal end of the femoral nerve
was passed through the previously removed male vein graft (C), and cut (1 mm) to obtain a fresh end. Using 10/0 monofilament nylon, the proximal
and distal stumps were drawn together and tied to form a loop while keeping a gap of,3 mm (D). Every effort was made to avoid tension and keep
correct rotational alignment throughout. Using the forceps, the femoral vein was pulled over the gap toward the proximal end of the nerve. The vein
graft was secured in place between ends of the femoral nerve with 10/0 monofilament nylon, using 2–3 epineurial stitching for each stump (E).
doi:10.1371/journal.pone.0024801.g003
Figure 2. Cell proliferation is inhibited by irradiation. The viable
cells from normal untreated and irradiated veins were separately
cultured on fibronectin-coated culture plates in EGM2 culture media.
Plotted are the normalized cell counts at each time point obtained from
the analysis of 3 independent experiments per group. The cells from
untreated veins showed an increased growth rate in comparison to cells
from irradiated veins (*P,0.001, Student’s t-test).
doi:10.1371/journal.pone.0024801.g002
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by very thin myelin sheaths when compared to the untreated graft
and uninjured control groups.
To further examine if the vessel-derived donor cells play a direct
role in the regeneration process, irradiated and decellularized
venous grafts were used in parallel experiments along with
untreated normal venous grafts. Four to six weeks after injury,
FISH was performed to detect Y-chromosome bearing nuclei (red)
which validated the presence of male donor-derived blood vessel
progenitor cells within the regenerated female nerves of untreated
venous grafts (arrows, Fig. 4E), but not in irradiated or
decellularized grafts (data not shown). These experiments support
our hypothesis demonstrating the participation of blood vessel-
derived cells in the support of axonal growth and restoration after
nerve injury.
Discussion
Since most tissues are vascularized, blood vessels have been
implicated as a potential source from which multipotent stem cells
could originate. Indeed, multi-lineage progenitor cells have
Figure 4. Untreated venous grafts exhibit more effective regeneration. (A) Eight weeks post-transplantation, Masson’s Trichrome staining
revealed absence of collagen matrix and adventitia of the grafted vein (blue) and defined nerve regeneration with perineurium surrounding the
nerve bundles (pink) in untreated graft. Thickening of the extracellular matrix and disorganized perineurium was obvious in irradiated and
decellularized grafted groups. (B) The cross-section of the regenerated nerve exhibited regenerated NF-positive axons (green) encompassed by
FluoroMyelin-positive Schwann cells (red) suggesting proper regeneration of the femoral nerve in untreated control grafts compared to irradiated or
decellularized grafts. Undamaged host artery shown with arrowheads was used as a reference point (A, B). (C) Toluidine blue staining and (D)
transmission electron microscopy at the mid-proximal sections confirm superior regeneration with larger myelinated axons including presence of
myelin-producing Schwann cells (arrows) surrounding the regenerated axons. Absence of connective tissue fibrosis was evident in untreated grafts
while both irradiated and decellularized grafts showed poor levels of nerve regeneration indicated by small myelinated Schwann cells with high
levels of connective tissue fibrosis marked by collagen. ‘‘Sc’’ corresponds to Schwann cells, ‘‘M’’ to myelin sheath, ‘‘Ax’’ to axon, and ‘‘Col’’ to collagen.
(E) Four to six weeks after injury, FISH performed for the detection of Y chromosomes, verified the active contribution of male donor-derived blood
vessel progenitor cells (Y chromosome-positive nuclei, red) in the regenerated female femoral nerve (host Schwann cell nuclei counterstained with
DAPI), which is shown in blue (see arrows, n = 6). A total of 32 rats were transplanted (24 untreated grafts, 4 irradiated grafts, and 4 decellularized
grafts). Scale bars represent 100 mm (A–C) or 10 mm (D).
doi:10.1371/journal.pone.0024801.g004
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recently been found to populate blood vessel walls, notably in
skeletal muscle [23], [24]. An interesting corollary to the latter
findings is the fact that venous grafts have been successfully used to
bridge nerve defects both experimentally and clinically [1–3], [6–
17], although the biological mechanisms have remained unknown.
In the present study, we put forward the hypothesis that nerve
repair is perhaps mediated by the contribution of cells migrating
from the implanted donor venous grafts into the injury site and
have shown at least one of the biological mechanisms that
contribute to the therapeutic benefits of vein wrapping. Indeed we
show that, vein decellularization, which destroys the residing cells
while the mechanical properties of the vessel are not impaired
[27], and irradiation, that causes cell depletion and prevents cell
migration and replication [25], [28] severely compromised nerve
regeneration. These experiments provide evidence that without
functional blood vessel-derived cell involvement, nerve regenera-
tion mediated by vein wrapping is limited. The proper nerve
regeneration and reduced endoneurial scarring seen when
untreated venous grafts were utilized as the nerve guide conduit
is believed to be due in part to i) the facilitation of graft invasion by
increased Schwann cell motility [29], ii) the decrease in fibroblast
infiltration [30], iii) the prevention of uncontrolled fiber outgrowth
[31] and neuroma formation [15], [16], iv) the improvement of
gliding on the smooth inner surface of the vein [9], and v) the
prevention of scar tissue formation [7]. Furthermore, the venous
conduits facilitate nerve regeneration through neovascularization
[14] and growth factor secretion [31].
Our sex-mismatch venous graft model revealed the active
participation of venous graft- derived cells in accelerating the
process of remyelination and regeneration. The cells were shown
to migrate from the venous nerve guide to the site of nerve injury
which was evidenced by the presence of donor-derived Y
chromosome possessing cells in regions of regenerated nerve.
The colocalizations of these cells with host female Schwann cell
nuclei reveal possible differentiation and/or fusion of vessel-
derived cells to glial cells. Further experiments are necessary to
reveal the identity of the donor cell types and the terminal fates of
the host-derived cells. It is noteworthy that nerve guides that
combine both muscle and vein have shown promising results for
regenerating larger nerve defects [32], [33]. Clinical applications
that have used combined muscle-vein grafting have led to efficient
nerve repair, both for motor and sensory nerves, with satisfactory
functional recovery in 85% of the patients [32]. We suggest that
the success of these muscle-vein grafts is due to the cells that are
contained therein including satellite cells (and other muscle
progenitor cells), myoendothelial cells, and pericytes. These cells
could then differentiate toward a glial lineage and/or secrete
exogenous trophic factors reinforcing the myelination and
regeneration in a paracrine manner.
This study demonstrated a key biological mechanism behind the
successful use of vein wrapping for nerve repair. The improved
axonal in-growth was shown to occur through cellular interactions
between the migrating cells emanating from the venous grafts and
the regenerating nerve stumps.
Materials and Methods
Vein decellularization and irradiation procedure
With the aid of an operating microscope (WILD M690; WILD
HEERBRUGG, Switzerland), segments of pure femoral veins
were isolated and decellularized according to a protocol previously
reported by Shaner et al. [26]. Briefly, isolated femoral veins were
placed into 0.075% sodium dodecyl sulfate (SDS; Bio-Rad
Laboratories) in PBS for 15 h at 37uC in a shaking water bath.
Subsequently, they were rinsed by agitation in PBS at 37uC for
15 min repeatedly for five times. This method of decellularization
has been confirmed to remove .94% of cells from the vein. For
irradiation study, the vein grafts were irradiated at 1000-rad
(4.4 min) dose.
MTT assay
The MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide] assay was carried out to evaluate cell viability
[34]. Sterile solution of MTT (5 mg/ml stock; Sigma) was added
to the culture dishes (0.1 ml/ml media) containing control and
experimental venous grafts, and the dishes were incubated for 30–
60 min at 37uC. Mitochondrial dehydrogenase of viable cells
cleaves the tetrazolium rings of the pale yellow MTT and form
purple formazan crystals which are impermeable to cell mem-
branes, thus resulting in its accumulation within healthy cells.
Presence of purple color was detected and captured using a Leica
DMIRB microscope equipped with a Retiga 1300 digital camera
(Q imaging) and Northern Eclipse software system (v. 6.0; Empix
Imaging, Inc.).
Cell proliferation
An equivalent number of viable cells were plated in fibronectin-
coated 24-well plates in endothelial cell growth media-2 (EGM2;
Table 1. Morphometric analysis of the regenerated myelinated axons.
Parameters measured Control femoral nerve Untreated graft Irradiated graft Decellularized graft
Number of myelinated axons 400 375 435 440
Myelinated fiber area (mm2) 21.9 (11.1–28.1) 13.01 (6.25–21.9) 5.251* (1.50–6.26) 3.811* (1.50–6.26)
Myelin thickness (mm) 9.72 (6.0–14.4) 5.861 (3.35–8.89) 2.871* (1.84–4.57) 2.051* (0.97–3.32)
Axonal area (mm2) 10.1 (5.93–13.3) 7.64 (2.08–12.2) 2.191* (0.77–4.26) 1.431* (0.24–2.85)
g-ratio 0.54 (0.40–0.61) 0.50 (0.42–0.57) 0.441* (0.14–0.54) 0.361* (0.14–0.51)
The median values for the number of the myelinated axons (per 10,000 mm2) at the mid-proximal portion of the regenerated nerve stained with toluidine blue showed
no significant difference between the groups (P=0.760; ANOVA, Kruskal-Wallis on Ranks). Parametric analyses of transmission electron microscopy images of the
proximal-mid cross-sections of the regenerated femoral nerve show that median (25th–75th) values of the myelinated fiber area and myelin thickness statistically differ
between the groups (*P,0.05; ANOVA, Kruskal-Wallis on Ranks) when compared to the control femoral nerve (1P,0.05; ANOVA, Kruskal-Wallis on Ranks). The
quantitative measurement of the axonal area and the g-ratio (axonal area : myelinated fiber area) showed no difference between the untreated graft and control
femoral nerve groups. The irradiated and decellularized groups showed significantly lower g-ratio associated with thinner axonal remyelination when compared to
untreated grafts (*P,0.05, ANOVA, Kruskal-Wallis on Ranks) and uninjured control femoral nerve (1P,0.05; ANOVA, Kruskal-Wallis on Ranks). The measured
morphometric parameters represent results from 3–4 mice per group and analysis of 300–400 myelinated fibers.
doi:10.1371/journal.pone.0024801.t001
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Lonza). The cell number in each group was counted with a
hemocytometer and standard trypan blue technique for cell
viability determination over a 10-day period from 3 independent
experiments.
Isolation and implantation of venous nerve guide
All animal experimentation including the surgical procedures
illustrated in Figure 2 were approved by the University of
Pittsburgh Institutional Animal care and use committee (Animal
Welfare Assurance Number A3187-01) under approved current
protocol #0810153A-2 (Formerly Protocol #13-03). Female
Fischer 344 rats weighing 100–125 grams and male Fischer 344
rats weighing 200–225 grams were obtained from Harlan
(Indianapolis, IN). Rats were initially anaesthetized using 4%
isoflurane (VETEQUIP Inc., CA) in O2 and maintained under
anesthesia using 1.5% isoflurane in O2. Under sterile conditions,
with the aid of an operating microscope (WILD M690; WILD
HEERBRUGG, Switzerland), a 5 to 6 mm segment of pure
femoral vein from a male rat was isolated, pulled over a 0.2 mm
forceps (vessel dilator), and placed in sterile saline solution for later
use. The right femoral nerve of a female rat was exposed through
anterior approach, and a 5 mm segment of peripheral nerve was
carefully separated so as not to disturb the attached artery and vein
compartment. Using surgical scissors, neurotomy was performed
in the middle of the femoral nerve. The distal end of the nerve was
passed through the previously removed male vein graft, and cut
(1 mm) to obtain a fresh end. Using a 10/0 monofilament suture,
the proximal and distal stumps were connected together and the
nylon was used to form a loop while keeping a gap of ,3–4 mm.
Every effort was made to avoid tension and keep correct rotational
alignment throughout. Using the forceps, the femoral vein was
pulled over the gap toward the proximal end of the nerve. The
vein graft was secured in place between ends of the femoral nerve
with 10/0 monofilament nylon, using 2–3 epineurial stitching for
each stump. A small knot was placed with a 4/0 silk suture on the
fascia of the muscle above the construct at the proximal and distal
end to allow easy identification at the time of harvest and
cryosectioning. Rats were monitored daily post-surgery for proper
recovery to assess and alleviate any signs of pain and distress. A
total of 32 rats received vein grafts for the sex-mismatched study
(24 untreated grafts, 4 irradiated grafts, and 4 decellularized grafts)
and 3 rats were used for sex-matched study as a negative control
for FISH analysis.
Histochemistry
For Masson’s Trichrome stain, the slides were processed as
detailed in the manufacturer’s protocol (Masson’s Trichrome stain
kit, K7228; IMEB Inc.), which stains collagen blue, muscle fibers
red, and nuclei black.
Immunohistochemistry
Cryosections of the reconstructed femoral nerves were first
immunostained for FluoroMyelin Red (Molecular Probes) accord-
ing to the protocol provided by the manufacturer, and then fixed
in 4% PFA, blocked with 5% donkey serum for 1 h, and incubated
with neurofilament (NF, 1:300, rabbit; Chemicon) antibody for
2 h at room temperature. Tissues were then rinsed with PBS and
stained with secondary antibody AlexaFluorH 488-conjugated for
20 min. Nuclei were revealed with DAPI. Fluorescent images were
captured and processed using a Nikon Eclipse E800 microscope
equipped with a Q imaging Retiga Exi digital camera using
Northern Eclipse software (v. 6.0; Empix Imaging Inc.).
Morphometric analysis of the regenerated nerve
To evaluate the degree of myelination, some of the recon-
structed femoral nerves including all tissue surrounding them,
were processed for light and transmission electron microscopy.
The contralateral sciatic nerves harvested at the same level served
as a ‘‘normal’’ control. Briefly, the tissues were fixed in 2.5%
glutaraldehyde (EM grade; Taab Chemical) in 0.1 M phosphate
buffer (pH 7.3; Fisher Scientific) overnight at 4uC. The nerves
were then rinsed in PBS, post-fixed in 1% osmium tetroxide
(Electron Microscopy Sciences) with 0.1% potassium ferricyanide
(Fisher Scientific), dehydrated in a series of ethanol solutions
(30%–90%; Fisher, and 100% [Ethanol 200 Proof]; Pharmco),
exposed to propylene oxide twice for 10 min each and embedded
in Epon (Dodecenyl Succinic Anhydride, Nadic Methyl Anhy-
dride, Scipoxy 812 Resin and Dimethylaminomethyl; Energy
Beam Sciences). All grafted segments were carefully oriented in
order to obtain sections perpendicular to their long axis. Semi-thin
(300 nm) sections were cut using a Leica Ultracut and stained with
0.5% toluidine blue (Fisher Scientific) and examined under a light
microscope (Olympus BX51) with Magnafire 2.1A image capture
software, and quantified for the number of myelinated axons. The
ultrathin sections (65 nm) were obtained at distal, mid, and
proximal ends using a Leica Ultracut Microtome and stained with
2% uranyl acetate (Electron Microscopy Sciences) and Reynold’s
lead citrate (Fisher Scientific), and examined on a JEOL JEM-
1011 transmission electron microscope. Each nerve section was
divided into four quarters and each quarter was analyzed
individually. Morphometric parameters of 300–400 fibers were
calculated following image capture, background subtraction,
image enhancement, automatic thresholding, and final editing.
The total number of myelinated axons was counted in
,10,000 mm2 of the cross-sectional area from the mid-sections
of the nerve, and median area of myelin thickness, median cross-
sectional area of myelinated axons, and g-ratio (axonal area/
myelinated fiber area) were examined.
Fluorescence in Situ Hybridization (FISH)
Venous graft cryosections (6 mm) were fixed in methanol : acetic
acid (3:1), dehydrated using 70, 80, 95, and 100% ethanol for
3 min each, air dried, and then denatured in 70% formamide-26
sodium chloride-sodium citrate (SSC) for 5 min at 6961uC. Slides
were then dehydrated as described above and air dried. Following
manufacture’s protocol, we applied the directly-labeled fluores-
cence rat-specific Y-chromosome-Cy3 and chromosome 12-FITC
probes (Cambio) to the target areas (area around the sections
marked with diamond scribe). The slides were covered with plastic
coverslips (VWR) then glued with rubber cement and incubated in
a humidity chamber for 18–24 h at 37uC. The next day, rubber
cement and coverslips were removed and the slides were washed
with 26 SSC for 5 min, followed by washes in 50% formamide-
26 SSC (12–13 min), 26 SSC (three times for 7 min) and 26
SSC-Tween (2 min). All washes were done in 45uC. Slides were
counterstained with DAPI and were mounted with VectashieldH
medium (Vector). The hybridized Y-chromosome-specific probe
was detected using a fluorescence microscope. Negative control
tissues were consisted of sex-matched venous grafts (female
femoral vein transplanted over the female femoral nerve) to check
for absence of the Y-chromosomes signals.
Statistics
All Statistical analyses were carried out using SigmaStat (Jandel
Scientific v2.0) software package. The Student’s t-test or Mann-
Whitney Rank Sum test was used for direct comparisons between
treated and untreated groups. For multiple comparisons, One-way
Venous Graft-Derived Cells Mediate Nerve Repair
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ANOVA or the Kruskal-Wallis One-way ANOVA on ranks
(where appropriate) was applied. A P value,0.05 was considered
significant. Morphometric parameters are expressed as the median
values, 25th–75th percentiles.
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